論文・総説 - 村上　正憲

21. Nakano Yujiro, Yoshimoto Takanobu, Fukuda Tatsuya, Murakami Masanori, Bouchi Ryotaro, Minami Isao, Hashimoto Koshi, Fujii Yasuhisa, Kihara Kazunori, Ogawa Yoshihiro. Effect of Eplerenone on the Glomerular Filtration Rate(GFR) in Primary Aldosteronism: Sequential Changes in the GFR During Preoperative Eplerenone Treatment to Subsequent Adrenalectomy Internal Medicine. 2018.09; 57 (17): 2459-2466. ( 医中誌 )

22. Fukuda Tatsuya, Bouchi Ryotaro, Takeuchi Takato, Nakano Yujiro, Murakami Masanori, Minami Isao, Izumiyama Hajime, Hashimoto Koshi, Yoshimoto Takanobu, Ogawa Yoshihiro. Ratio of visceral-to-subcutaneous fat area predicts cardiovascular events in patients with type 2 diabetes Journal of Diabetes Investigation. 2018.03; 9 (2): 396-402. ( 医中誌 )

23. Fukuda Tatsuya, Bouchi Ryotaro, Takeuchi Takato, Nakano Yujiro, Murakami Masanori, Minami Isao, Izumiyama Hajime, Hashimoto Koshi, Yoshimoto Takanobu, Ogawa Yoshihiro. Ratio of visceral-to-subcutaneous fat area predicts cardiovascular events in patients with type 2 diabetes JOURNAL OF DIABETES INVESTIGATION. 2018.03; 9 (2): 396-402. ( PubMed, DOI )

24. Masuda Seizaburo, Murakami Masanori, Bouchi Ryotaro, Minami Isao, Hashimoto Koshi, Yoshimoto Takanobu, Ogawa Yoshihiro. Repeated Hypoglycemic Episodes with Postprandial Hyperinsulinemia after the Recovery from Acute Weight Loss Revealed by Continuous Glucose Monitoring and the Oral Glucose Tolerance Test Internal Medicine. 2018.03; 57 (5): 697-700. ( 医中誌 )

25. Bouchi Ryotaro, Fukuda Tatsuya, Takeuchi Takato, Nakano Yujiro, Murakami Masanori, Minami Isao, Izumiyama Hajime, Hashimoto Koshi, Yoshimoto Takanobu, Ogawa Yoshihiro. Dipeptidyl peptidase 4 inhibitors attenuates the decline of skeletal muscle mass in patients with type 2 diabetes DIABETES-METABOLISM RESEARCH AND REVIEWS. 2018.02; 34 (2): ( PubMed, DOI )

26. Masuda Seizaburo, Murakami Masanori, Bouchi Ryotaro, Minami Isao, Hashimoto Koshi, Yoshimoto Takanobu, Ogawa Yoshihiro. Repeated Hypoglycemic Episodes with Postprandial Hyperinsulinemia after the Recovery from Acute Weight Loss Revealed by Continuous Glucose Monitoring and the Oral Glucose Tolerance Test INTERNAL MEDICINE. 2018; 57 (5): 697-700. ( PubMed, DOI )

27. Nakano, Y; Yoshimoto, T; Fukuda, T; Murakami, M; Bouchi, R; Minami, I; Hashimoto, K; Fujii, Y; Kihara, K; Ogawa, Y. Effect of Eplerenone on the Glomerular Filtration Rate (GFR) in Primary Aldosteronism: Sequential Changes in the GFR During Preoperative Eplerenone Treatment to Subsequent Adrenalectomy INTERNAL MEDICINE. 2018; 57 (17): 2459-2466. ( PubMed, DOI )

28. Fukuda Tatsuya, Bouchi Ryotaro, Takeuchi Takato, Nakano Yujiro, Murakami Masanori, Minami Isao, Izumiyama Hajime, Hashimoto Koshi, Yoshimoto Takanobu, Ogawa Yoshihiro. Association of diabetic retinopathy with both sarcopenia and muscle quality in patients with type 2 diabetes: a cross-sectional study BMJ OPEN DIABETES RESEARCH & CARE. 2017.11; 5 (1): e000404. ( PubMed, DOI )

29. Okuma Hideyuki, Bouchi Ryotaro, Masuda Seizaburo, Takeuchi Takato, Murakami Masanori, Minami Isao, Izumiyama Hajime, Hashimoto Koshi, Yoshimoto Takanobu, Ogawa Yoshihiro. 膵全摘術後の糖尿病患者ではオクトレオチドによる膵外グルカゴンの分泌抑制によって空腹時・食後血糖値が低下する可能性がある(Suppression of Extrapancreatic Glucagon by Octreotide May Reduce the Fasting and Postprandial Glucose Levels in a Diabetic Patient after Total Pancreatectomy) Internal Medicine. 2017.11; 56 (22): 3061-3066. ( 医中誌 )

30. Masanori Murakami, Takanobu Yoshimoto, Kazuhiko Nakabayashi, Yujiro Nakano, Takahiro Fukaishi, Kyoichiro Tsuchiya, Isao Minami, Ryotaro Bouchi, Kohji Okamura, Yasuhisa Fujii, Koshi Hashimoto, Ken-Ichiro Hata, Kazunori Kihara, Yoshihiro Ogawa. Molecular characteristics of the KCNJ5 mutated aldosterone-producing adenomas. Endocr Relat Cancer. 2017.10; 24 (10): 531-541. ( PubMed, DOI )

31. Fukuda Tatsuya, Bouchi Ryotaro, Terashima Masahiro, Sasahara Yuriko, Asakawa Masahiro, Takeuchi Takato, Nakano Yujiro, Murakami Masanori, Minami Isao, Izumiyama Hajime, Hashimoto Koshi, Yoshimoto Takanobu, Ogawa Yoshihiro. Ipragliflozin Reduces Epicardial Fat Accumulation in Non-Obese Type 2 Diabetic Patients with Visceral Obesity: A Pilot Study DIABETES THERAPY. 2017.08; 8 (4): 851-861. ( PubMed, DOI )

32. Bouchi Ryotaro, Fukuda Tatsuya, Takeuchi Takato, Nakano Yujiro, Murakami Masanori, Minami Isao, Izumiyama Hajime, Hashimoto Koshi, Yoshimoto Takanobu, Ogawa Yoshihiro. Insulin Treatment Attenuates Decline of Muscle Mass in Japanese Patients with Type 2 Diabetes CALCIFIED TISSUE INTERNATIONAL. 2017.07; 101 (1): 1-8. ( PubMed, DOI )

33. Bouchi Ryotaro, Fukuda Tatsuya, Takeuchi Takato, Nakano Yujiro, Murakami Masanori, Minami Isao, Izumiyama Hajime, Hashimoto Koshi, Yoshimoto Takanobu, Ogawa Yoshihiro. Association of sarcopenia with both latent autoimmune diabetes in adults and type 2 diabetes: a cross-sectional study JOURNAL OF DIABETES AND ITS COMPLICATIONS. 2017.06; 31 (6): 992-996. ( PubMed, DOI )

34. Bouchi Ryotaro, Terashima Masahiro, Sasahara Yuriko, Asakawa Masahiro, Fukuda Tatsuya, Takeuchi Takato, Nakano Yujiro, Murakami Masanori, Minami Isao, Izumiyama Hajime, Hashimoto Koshi, Yoshimoto Takanobu, Ogawa Yoshihiro. Luseogliflozin reduces epicardial fat accumulation in patients with type 2 diabetes: a pilot study CARDIOVASCULAR DIABETOLOGY. 2017.03; 16 (1): 32. ( PubMed, DOI )

35. Bouchi Ryotaro, Nakano Yujiro, Fukuda Tatsuya, Takeuchi Takato, Murakami Masanori, Minami Isao, Izumiyama Hajime, Hashimoto Koshi, Yoshimoto Takanobu, Ogawa Yoshihiro. リラグルチドによる内臓脂肪の減少は2型糖尿病患者に対するインスリン治療に伴う肝脂肪変性、アルブミン尿、微小炎症の緩和と関連する　無作為化比較試験(Reduction of visceral fat by liraglutide is associated with ameliorations of hepatic steatosis, albuminuria, and micro-inflammation in type 2 diabetic patients with insulin treatment: a randomized control trial) Endocrine Journal. 2017.03; 64 (3): 269-281. ( 医中誌 )

36. Bouchi R, Nakano Y, Fukuda T, Takeuchi T, Murakami M, Minami I, Izumiyama H, Hashimoto K, Yoshimoto T, Ogawa Y. Reduction of visceral fat by liraglutide is associated with ameliorations of hepatic steatosis, albuminuria, and micro-inflammation in type 2 diabetic patients with insulin treatment: a randomized control trial. Endocrine journal. 2017.03; 64 (3): 269-281. ( PubMed, DOI )

37. Bouchi R, Fukuda T, Takeuchi T, Nakano Y, Murakami M, Minami I, Izumiyama H, Hashimoto K, Yoshimoto T, Ogawa Y. Gender difference in the impact of gynoid and android fat masses on the progression of hepatic steatosis in Japanese patients with type 2 diabetes. BMC obesity. 2017; 4 27. ( PubMed, DOI )

38. Okuma Hideyuki, Bouchi Ryotaro, Masuda Seizaburo, Takeuchi Takato, Murakami Masanori, Minami Isao, Izumiyama Hajime, Hashimoto Koshi, Yoshimoto Takanobu, Ogawa Yoshihiro. Suppression of Extrapancreatic Glucagon by Octreotide May Reduce the Fasting and Postprandial Glucose Levels in a Diabetic Patient after Total Pancreatectomy INTERNAL MEDICINE. 2017; 56 (22): 3061-3066. ( PubMed, DOI )

39. Bouchi Ryotaro, Nakano Yujiro, Fukuda Tatsuya, Takeuchi Takato, Murakami Masanori, Minami Isao, Izumiyama Hajime, Hashimoto Koshi, Yoshimoto Takanobu, Ogawa Yoshihiro. Reduction of visceral fat by liraglutide is associated with ameliorations of hepatic steatosis, albuminuria, and micro-inflammation in type 2 diabetic patients with insulin treatment: a randomized control trial ENDOCRINE JOURNAL. 2017; 64 (3): 269-281.

40. Masanori Murakami, Takanobu Yoshimoto, Yujiro Nakano, Kyoichiro Tsuchiya, Isao Minami, Ryotaro Bouchi, Yasuhisa Fujii, Kazuhiko Nakabayashi, Koshi Hashimoto, Ken-Ichiro Hata, Kazunori Kihara, Yoshihiro Ogawa. Expression of inflammation-related genes in aldosterone-producing adenomas with KCNJ5 mutation. Biochem Biophys Res Commun. 2016.08; 476 (4): 614-619. ( PubMed, DOI )